IBD Stock Of The Day, Travere Therapeutics, Tests Another Breakout. Can The Stock Get Any 'Sweeter?'
We haven't written up this one. Yahoo Finance has the full story — the link below goes straight to it.
More in Finance & Markets
5 things to know about the Chinese e-commerce juggernaut Shein ahead of its IPO
The fast-fashion giant is targeting a listing in Hong Kong by Sept. 1. It’s been trying to go public for four years.
5 things to know about the Chinese e-commerce juggernaut Shein ahead of its IPO
The fast-fashion giant is targeting a listing in Hong Kong by Sept. 1. It’s been trying to go public for four years.
United Kingdom: Resilient growth outlook – Deutsche Bank
Deutsche Bank Research, led by Sanjay Raja and Maui Brennan, highlights the United Kingdom (UK) economy’s surprising resilience to the Iran-related energy shock in 2026.
Bond Moves Not a Surprise, Says CFR's Patterson
Rebecca Patterson, Council on Foreign Relations senior fellow, talks about how volatility in the bond market is impacting retail investors on "Bloomberg Money." (Source: Bloomberg)
What to Look Out for at the Fed’s Jackson Hole Gathering
On course for one of the most interesting symposiums in recent years.
What's happening with the national debt — and how it could affect your wallet
America's national debt rose to over $40 trillion this week, and it might mean your mortgage or auto loans could get more expensive.